21 CFR § 4.100 Regulation of Combination Products

§ 4.100 What is the scope of this subpart?

Current through Sep 8, 2026 · Read all of Part 4

(a) This subpart identifies postmarketing safety reporting requirements for combination product applicants and constituent part applicants.

(b) This subpart does not apply to investigational combination products, combination products that have not received marketing authorization, or to persons other than combination product applicants and constituent part applicants.

(c) This subpart supplements and does not supersede other provisions of this chapter, including the provisions in parts 314, 600, 606, 803, and 806 of this chapter, unless a regulation explicitly provides otherwise.

← § 4.4 How can I comply with these current good manufacturing practice requirements for a co-packaged or single-entity combination product?§ 4.101 How does the FDA define key terms and phrases in this subpart? →